SESSION 1: MOLECULAR PATHOLOGY AND BIOMARKERS IN AGE-RELATED MACULAR DEGENERATION (AMD)
Macular degeneration. Where we are in clinical practice, J.Monés.
Anti PDGF therapy for exudative AMD: addressing the fibrosis pathway, S.Patel.
Markers and Mechanisms in Maculopathies: a systems view, M.Ueffing.
Towards a systems-oriented view of the molecular pathology of AMD, C.Kiel.
Cellular response associated to retinal diseases and therapeutics approaches, N.Cuenca.
KEYNOTE SPEAKER: A molecular road to a therapy for Dry AMD, J.Ambati.
SESSION 2: NANOTECHNOLOGY
Medical Nanochemistry, the use of reactive inorganic nanoparticles in medicine, V.Puntes.
Non-viral gene delivery for the treatment of inherited retinal disorders, G.Puras Ochoa.
Retinal degenerations: Animal models and new therapeutical approaches, G.Martínez Navarrete.
SESSION 3: GENETICS AND GENE THERAPY
Genetics. The case of the EYE RISK project. C.Klaver.
The role of mithocondrial genetics on the development of AMD, B.Kupperman.
Gene therapy in retinal degenerative diseases, looking for therapeutic targets, F.Díaz Corrales.
SESSION 4: PHOTONICS AND IMAGING
The use of advanced microscopy techniques for ophthalmological applications, P.Loza.
High resolution retinal imaging: the case of LITE project, D.Merino.
From taking a PEEK to wide-field imaging: how imaging best serves translational research?, T.Peto.
SESSION 5: OPTOGENETICS AND ARTIFICIAL VISION
Visual neuroprosthesis: Current status and future prospects, E.Fernández.
KEYNOTE SPEAKER: OPTOGENETICS, M.Zarbin.
SESSION 6: REGENERATIVE THERAPY. STEM CELLS
Advanced cell therapies for AMD, B.de la Cerda Haynes.
Pluripotent stem cells for retinal disease, research and clinical application, A.Veiga.
Use of induced pluripotent stem cells and direct lineage reprogramming in cell therapy for eye regenerative medicine, B.Álvarez.
Improving the quality and characterisation of stem cell reprogramming and analysing the genomic stability and immune response, M.Edel.
Adult progenitor stem cells: applications for cell-based therapy in degenerative retinal diseases, R.Casaroli.
Retinal regeneration via cell fusion mediated reprogramming, P.Cosma.
SESSION 7: ROUND TABLE. FROM BENCH TO BEDSIDE
KEYNOTE SPEAKER: HIV brought us to Microbiome study, B.Clotet.
Research transfer, X.Rubíes.
Technology transfer, S.Artigas.
Innovative schemes though demand-driven procurement for procuring early detection services: the case of the PRo4VIP, R.Maspons.